We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

I asked ChatGPT for the best FTSE 100 shares to consider for 2026, and it said…

Whatever an individual investor’s favourite strategy, I reckon there’s something for everyone among the shares in the FTSE 100.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

ChatGPT’s found me some popular FTSE 100 shares to mull going into the New Year. But I think some would put me on the road to nowhere. So I’ve had to use my human brain to barrow down my search criteria and pick candidates in three different categories.

Looking for relatively safe blue-chips, pharmaceutical giant AstraZeneca (LSE: AZN) is one I’ll definitely look at. AstraZeneca has a forward price-to-earnings (P/E) ratio of 27, with the share price having soared 90% in the past five years. With a forecast dividend yield of just 1.7%, it might not look great value, but as defensive stocks go, it has to be a consideration.

Should you buy AstraZeneca Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

With the latest update in November, CEO Pascal Soriot spoke of “an unprecedented 16 positive Phase III trials this year, with four since our previous results including high-impact readouts for baxdrostat in hypertension and Enhertu and Datroway in breast cancer.

He also pointed to expansion in the US, with construction of the company’s new $4.5bn manufacturing facility in Virginia already commenced. These highlight the key strengths for me. AstraZeneca’s share valuation might be the biggest danger, especially if investors move away from safety in 2026. But its very strong pipeline and global market reach lead me to rate it a definite long-term consideration.

FTSE 100 growth

The FTSE 100 isn’t really home to many growth candidates, but Rio Tinto (LSE: RIO) enjoyed a bit of cyclical growth in the latter half of 2025. And with the share price up only 7% in five years, I see a good chance of more to come.

Global demand for metals has been strong. I can see solid demand for quite some time yet, especially if China gets back into top gear. Even with a slight slowdown predicted, GDP growth for the country is expected to come in between 4% and 5% this year. Most Western economies can only dream of that.

My main concern is if precious metal fever subsides — which it surely must, right? Rio does produce some gold and silver, and it could take a hit. But it’s a major supplier of copper, aluminium and iron. And it also unearths lithium, selenium, molybdenum and many more in demand by various high-tech industries. Add in a 4.8% forecast dividend yield, and Rio Tinto has to be one to consider for 2026.

Show me the cash

For FTSE 100 income, I like the 4.7% dividend yield on the cards for Prudential (LSE: PRU). That’s higher than we were used to from the Pru of old. And it comes even after the share price has gained nearly 50% in five years. It is however, worth noting that the share price is only about where it was back in 2018.

Maybe today’s higher valuation could weigh against the stock in the future. This is a cyclical business, after all — and a P/E of 14 might be a bit toppy for the sector.

But I reckon Prudential’s key strength lies in its Asian prospects. At Q3 time, CEO Anil Wadhwani praised the “particular focus on ASEAN markets where we see an opportunity to build on the agency new business profit growth achieved in the markets of Greater China.”

So I’m considering the Pru for my 2026 Stocks and Shares ISA.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc and Prudential Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

How have BAE Systems shares become a dividend powerhouse? 5 reasons why!

Dividends on BAE Systems shares have risen every year without fail since the early 2000s. So what's the FTSE 100…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

Want to retire early? Here’s how a weak stock market could actually help

Christopher Ruane demonstrates with a real-world example how a tumbling stock market could potentially help someone who wants to retire…

Read more »

Tanker coming in to dock in calm waters and a clear sunset
Investing Articles

BP shares: still priced as an oil major — but the market may be behind the curve

Andrew Mackie looks at BP shares and why investors may be underestimating the quality and concentration of its underlying asset…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

At 8.1%, are investors missing the bigger story behind Legal & General shares?

Andrew Mackie explores Legal & General shares and asks whether investors are still viewing it too narrowly as a yield…

Read more »

Young black female footballer training on stadium pitch
Investing Articles

How has this FTSE 250 share surged ANOTHER 7% today?

Applied Nutrition shares have soared on Monday after another brilliant trading update. So what's the FTSE 250 company's secret?

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

The stock market game you’re actually playing (and why you might be losing)

Our writer recounts a painful experience of making a rash stock market decision based on emotions, not logic – and…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Why is EasyJet stock suddenly a takeover target for US investors?

Andrew Mackie looks at easyjet shares jumping on US takeover talk — but is this a genuine re-rating or just…

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

Have investors got BT shares all wrong?

BT shares spiked during the 1990s telecom boom, then struggled for two decades. Harvey Jones says it's the future that…

Read more »